In contrast, patients with viral-related HCC have an improved prognosis when their CD8+ T cells are activated and produce chemokine X-C motif chemokine ligand 1 (XCL1), which enhances the tumor-attacking immune response by activating other immune cells [48]. This evidence concerns the gene CD8A and hepatocellular carcinoma.